Xu A - Search Results

1

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.

Li H, Fang Q, Gao F, Fan J, Zhou J, Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A, Jia W. Li H, et al. Among authors: xu a. J Hepatol. 2010 Nov;53(5):934-40. doi: 10.1016/j.jhep.2010.05.018. Epub 2010 Jul 17. J Hepatol. 2010. PMID: 20675007

2

Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.

Li H, Bao Y, Xu A, Pan X, Lu J, Wu H, Lu H, Xiang K, Jia W. Li H, et al. Among authors: xu a. J Clin Endocrinol Metab. 2009 Jun;94(6):2151-6. doi: 10.1210/jc.2008-2331. Epub 2009 Mar 24. J Clin Endocrinol Metab. 2009. PMID: 19318452

3

Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.

Milner KL, van der Poorten D, Xu A, Bugianesi E, Kench JG, Lam KS, Chisholm DJ, George J. Milner KL, et al. Among authors: xu a. Hepatology. 2009 Jun;49(6):1926-34. doi: 10.1002/hep.22896. Hepatology. 2009. PMID: 19475694

4

Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans.

Yu H, Xia F, Lam KS, Wang Y, Bao Y, Zhang J, Gu Y, Zhou P, Lu J, Jia W, Xu A. Yu H, et al. Among authors: xu a. Clin Chem. 2011 May;57(5):691-700. doi: 10.1373/clinchem.2010.155184. Epub 2011 Feb 15. Clin Chem. 2011. PMID: 21325103

5

Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.

Xiao Y, Xu A, Law LS, Chen C, Li H, Li X, Yang L, Liu S, Zhou Z, Lam KS. Xiao Y, et al. Among authors: xu a. J Clin Endocrinol Metab. 2012 Jan;97(1):E54-8. doi: 10.1210/jc.2011-1930. Epub 2011 Oct 19. J Clin Endocrinol Metab. 2012. PMID: 22013098

6

Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.

Ye D, Li FY, Lam KS, Li H, Jia W, Wang Y, Man K, Lo CM, Li X, Xu A. Ye D, et al. Among authors: xu a. Gut. 2012 Jul;61(7):1058-67. doi: 10.1136/gutjnl-2011-300269. Epub 2012 Jan 17. Gut. 2012. PMID: 22253482

7

Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3.

Li H, Gao Z, Zhang J, Ye X, Xu A, Ye J, Jia W. Li H, et al. Among authors: xu a. Diabetes. 2012 Apr;61(4):797-806. doi: 10.2337/db11-0846. Epub 2012 Feb 14. Diabetes. 2012. PMID: 22338096 Free PMC article.

8

Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure.

Liu M, Zhou M, Bao Y, Xu Z, Li H, Zhang H, Zhu W, Zhang J, Xu A, Wei M, Jia W. Liu M, et al. Among authors: xu a, xu z. Clin Sci (Lond). 2013 Jan;124(2):115-22. doi: 10.1042/CS20120004. Clin Sci (Lond). 2013. PMID: 23013043

9

Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.

Hoo RL, Lee IP, Zhou M, Wong JY, Hui X, Xu A, Lam KS. Hoo RL, et al. Among authors: xu a. J Hepatol. 2013 Feb;58(2):358-64. doi: 10.1016/j.jhep.2012.10.022. Epub 2012 Oct 26. J Hepatol. 2013. PMID: 23108115

10

High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China.

Li H, Dong K, Fang Q, Hou X, Zhou M, Bao Y, Xiang K, Xu A, Jia W. Li H, et al. Among authors: xu a. J Hepatol. 2013 Mar;58(3):557-63. doi: 10.1016/j.jhep.2012.10.029. Epub 2012 Nov 7. J Hepatol. 2013. PMID: 23142063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,928 results

Search Page

Filters